Research ArticleResearchQuality ImprovementWorkflow

Nasal apneic oxygenation prevented intubation desaturation in one pediatric trial

Anesthesiology and Pain Medicine (PubMed)Feb 27, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A randomized trial of 140 children undergoing adenotonsillectomy found that nasal-cannula apneic oxygenation maintained higher oxygen saturation during intubation than standard intubation.

What NurseJet pulled from the source

Children aged 3 to 10 years were randomized to standard intubation or nasal oxygen at 0.2 L/kg/min during apnea. No child in the oxygen group desaturated to 95% or below, compared with 21.43% of controls; intubation time, attempts, and bradycardia did not differ significantly.

Why this matters for nurses

Perioperative pediatric nurses help prepare oxygen-delivery equipment, monitor oxygenation, and communicate changes during airway management. This trial supports protocol review for a defined high-risk airway setting without establishing a universal approach for every pediatric intubation.

Bedside takeaway

Apply apneic oxygenation only through the approved pediatric airway protocol and continue continuous oxygenation monitoring.

Key takeaways

Mean lowest oxygen saturation during intubation was 99.91% with apneic oxygenation and 97.40% with standard care.
Severe desaturation below 92% occurred in 7.14% of controls and in none of the children receiving apneic oxygenation.
The result applies to children undergoing adenotonsillectomy under the studied anesthesia protocol.

Practice implications

Use apneic oxygenation only within the anesthesia team's approved pediatric airway protocol, verify the ordered equipment and flow, continuously monitor oxygenation, and communicate any desaturation or airway difficulty immediately.

Limitations & cautions

This was one single-blinded trial in children aged 3 to 10 undergoing adenotonsillectomy. The abstract does not describe longer-term outcomes or establish effectiveness for other procedures, age groups, emergency intubation, or different oxygen-flow protocols.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Anesthesiology and Pain Medicine (PubMed)

Anesthesiology and Pain Medicine (PubMed). Effectiveness of Apneic Oxygenation During Induction of General Anesthesia in Children Undergoing Adenotonsillectomy: A Prospective Randomized Controlled Study.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42763625/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Pediatrics (PubMed)Sep 21, 2026Research Article

A large health-system implementation study found that hybrid congenital CMV screening was feasible and increased case detection, while follow-up audiology access remained a major gap.

Peds L&D / OBAI summaryReview source

Research ArticleResearchQuality ImprovementPatient EducationAI summary · original source linked below

Among 50,438 births from 2022 through 2025, 7,491 infants were screened using universal NICU screening plus targeted newborn-nursery screening. Thirty-four infants had confirmed congenital CMV, and case detection increased about 2.5-fold after implementation.

Key takeaways

Annual screening increased from about 150 infants to more than 2,000 after the multidisciplinary program was introduced.
Confirmed congenital CMV was detected in 0.45% of screened infants, with higher detection in the targeted group than the universal NICU group.
Logistical, socioeconomic, and educational barriers limited audiology follow-up despite successful integration of screening workflows.

Why this matters on shift

Newborn and pediatric nurses support specimen collection, parent education, result communication, and follow-up coordination. The study shows that screening implementation can improve detection, but the clinical benefit depends on families reaching audiology and other indicated follow-up services.

Bedside takeaway

Screening only helps when results and audiology follow-up are reliably carried through after discharge.

Nursing implications

Follow the facility's newborn CMV screening criteria and specimen workflow, document completion and results, explain the planned next steps in plain language, and help close audiology and pediatric follow-up loops before and after discharge.

Limitations & cautions

This was a retrospective implementation study in one Ohio health system rather than a randomized comparison. The screening approach combined universal NICU and targeted nursery testing, and the abstract does not establish a nationally preferred protocol or long-term outcome benefit.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Pediatrics (PubMed). Implementing Congenital CMV Screening in a Large Hospital System.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Supportive Care in Cancer (PubMed)Sep 20, 2026Systematic Review

A qualitative systematic review found that families of children with cancer experienced sustained financial strain from direct and indirect costs, lost income, and gaps in insurance or social support.

Oncology PedsAI summaryReview source

Systematic ReviewResearchPatient EducationWorkflowAI summary · original source linked below

The review synthesized 14 moderate-to-high-quality studies involving 524 participants, primarily parents, across seven countries. Families described debt, reduced living standards, psychosocial effects, and long-term vulnerability; financial assistance and reorganizing family life often provided only partial relief.

Key takeaways

Financial toxicity accumulated from medical expenses, indirect costs, employment disruption, and inadequate insurance or social support.
The burden extended beyond treatment and affected household stability, living standards, and psychosocial wellbeing.
Families used financial assistance and major changes to work and daily life, but these strategies often did not fully relieve the burden.

Why this matters on shift

Oncology and pediatric nurses may hear practical barriers before they appear in formal screening. The review supports treating cost, work disruption, travel, and access to assistance as parts of family-centered supportive care rather than assuming families will raise them independently.

Bedside takeaway

Screen early for treatment-related financial strain and route concerns through the pediatric oncology support pathway.

Nursing implications

Ask families whether treatment-related costs, travel, missed work, or access to basic needs are creating difficulty, document the concern, and connect them with the oncology social worker, financial navigator, or other approved support pathway early.

Limitations & cautions

This was a qualitative synthesis rather than an intervention study, so it does not estimate prevalence or prove that a specific support program improves outcomes. Most participants were parents, and experiences may differ across health systems and family structures.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Supportive Care in Cancer (PubMed). Financial toxicity among families of children with cancer: a qualitative systematic review and meta-aggregation.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Lancet (PubMed)Sep 19, 2026Research Article

In a double-blind randomized trial of infants at increased risk for asthma, two years of oral OM-85 did not delay or reduce the first wheezing lower respiratory tract illness during the following three years compared with placebo.

Peds Med-SurgAI summaryReview source

Research ArticleResearchMedication SafetyPatient EducationAI summary · original source linked below

The ORBEX trial randomized 822 children aged 6 to 18 months. During the off-treatment observation period, wheezing illness occurred in 71 of 342 children in the OM-85 group and 61 of 339 in the placebo group (HR 1.16; 95% CI 0.82 to 1.64), with no significant difference in the primary outcome.

Key takeaways

Children received OM-85 or placebo for 10 days each month over 24 months, followed by 36 months of observation off treatment.
The trial did not find a significant difference in time to first wheezing lower respiratory tract illness during observation.
Fevers, coughs, and colds were the most frequent adverse events and did not differ between groups.

Why this matters on shift

Families of young children at elevated asthma risk may ask about products promoted to prevent future wheezing. This large trial does not support presenting OM-85 as an effective primary-prevention strategy for asthma-like symptoms in this population.

Bedside takeaway

Do not present OM-85 as proven prevention for preschool wheezing; reinforce the child's prescribed respiratory plan instead.

Nursing implications

Use the child's prescribed wheeze or asthma action plan for symptom recognition and escalation, and avoid suggesting bacterial lysate products as proven primary prevention. Direct product questions to the pediatric clinician and follow local respiratory-care protocols.

Limitations & cautions

The trial enrolled children with selected asthma-risk factors at 11 U.S. academic sites, and 596 of 822 randomized children completed the full observation period. The result addresses OM-85 for primary prevention in this population, not treatment of established asthma or acute wheezing.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Lancet (PubMed). Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Hybrid congenital CMV screening increased detection across one hospital system

Pediatric cancer costs created sustained financial strain across 14 qualitative studies

OM-85 did not prevent preschool wheezing illness in the ORBEX trial